Alashinol G

CAS No. 58139-12-1

Alashinol G( (-)-Carinol )

Catalog No. M29472 CAS No. 58139-12-1

Alashinol G is isolated from the stem bark of Syringa pinnatifolia, a Mongolian folk medicine with anti-myocardial ischaemic effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 302 Get Quote
10MG 447 Get Quote
25MG 714 Get Quote
50MG 1017 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Alashinol G
  • Note
    Research use only, not for human use.
  • Brief Description
    Alashinol G is isolated from the stem bark of Syringa pinnatifolia, a Mongolian folk medicine with anti-myocardial ischaemic effects.
  • Description
    Alashinol G is isolated from the stem bark of Syringa pinnatifolia, a Mongolian folk medicine with anti-myocardial ischaemic effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (-)-Carinol
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    58139-12-1
  • Formula Weight
    754.82
  • Molecular Formula
    C40H50O14
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc(cc(C[C@@H](CO)[C@@](Cc(cc1)cc(OC)c1O)(CO)O)cc1)c1OCOc(cc(C[C@@H](CO)[C@@](Cc(cc1)cc(OC)c1O)(CO)O)cc1)c1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 2-Chloro-4-nitrophen...

    2-Chloro-4-nitrophenol is a chemical compound.

  • Cucurbitacin IIa 2-O...

    Cucurbitacin IIa 2-O-β-D-glucoside is a glycoside cucurbitacin isolated from the genus Hemsleya (Cucurbitaceae). Extracts of Hemsleya have the potential to be used in research on bronchitis, bacillary dysentery, and tuberculosis.

  • Dehydrojuncusol

    Dehydrojuncusol, a new inhibitor of hepatitis C virus RNA replication, it inhibits infection of different HCV genotypes by targeting the NS5A protein and is active against resistant HCV variants frequently found in patients with treatment failure.